Tredje AP-fonden’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.2M | Sell |
115,995
-16,389
| -12% | -$7.87M | 0.26% | 70 |
|
|
2026
Q1 | $65.1M | Sell |
132,384
-22,210
| -14% | -$12.1M | 0.36% | 52 |
|
|
2025
Q4 | $89.6M | Sell |
154,594
-15,377
| -9% | -$8.7M | 0.67% | 31 |
|
|
2025
Q3 | $82.4M | Sell |
169,971
-32,000
| -16% | -$14.9M | 0.66% | 35 |
|
|
2025
Q2 | $81.9M | Buy |
201,971
+62,279
| +45% | +$26M | 0.65% | 38 |
|
|
2025
Q1 | $69.5M | Sell |
139,692
-5,865
| -4% | -$3.18M | 0.65% | 40 |
|
|
2024
Q4 | $75.7M | Buy |
145,557
+23,968
| +20% | +$13.2M | 0.68% | 36 |
|
|
2024
Q3 | $75.2M | Buy |
121,589
+9,040
| +8% | +$5.35M | 0.68% | 36 |
|
|
2024
Q2 | $62.2M | Sell |
112,549
-3,380
| -3% | -$1.94M | 0.6% | 40 |
|
|
2024
Q1 | $67.4M | Buy |
115,929
+10,800
| +10% | +$6.06M | 0.7% | 35 |
|
|
2023
Q4 | $55.8M | Buy |
105,129
+10,590
| +11% | +$5.13M | 0.7% | 32 |
|
|
2023
Q3 | $47.9M | Sell |
94,539
-789
| -0.8% | -$420K | 0.71% | 30 |
|
|
2023
Q2 | $49.7M | Buy |
95,328
+2,478
| +3% | +$1.34M | 0.71% | 30 |
|
|
2023
Q1 | $53.5M | Buy |
92,850
+9,074
| +11% | +$5.11M | 0.83% | 24 |
|
|
2022
Q4 | $46.1M | Buy |
83,776
+2,047
| +3% | +$1.08M | 0.79% | 26 |
|
|
2022
Q3 | $41.5M | Buy |
81,729
+20,999
| +35% | +$11.8M | 0.86% | 21 |
|
|
2022
Q2 | $33M | Hold |
60,730
| – | – | 0.83% | 24 |
|
|
2022
Q1 | $35.9M | Sell |
60,730
-500
| -0.8% | -$287K | 0.73% | 25 |
|
|
2021
Q4 | $40.9M | Buy |
61,230
+935
| +2% | +$584K | 0.79% | 22 |
|
|
2021
Q3 | $34.4M | Buy |
60,295
+12,000
| +25% | +$6.59M | 0.72% | 27 |
|
|
2021
Q2 | $24.4M | Hold |
48,295
| – | – | 0.5% | 46 |
|
|
2021
Q1 | $22M | Sell |
48,295
-1,700
| -3% | -$811K | 0.53% | 50 |
|
|
2020
Q4 | $23.3M | Buy |
49,995
+16,000
| +47% | +$7.5M | 0.6% | 46 |
|
|
2020
Q3 | $15M | Hold |
33,995
| – | – | 0.49% | 53 |
|
|
2020
Q2 | $12.3M | Hold |
33,995
| – | – | 0.51% | 51 |
|
|
2020
Q1 | $9.64M | Buy |
33,995
+2,054
| +6% | +$648K | 0.5% | 47 |
|
|
2019
Q4 | $10.4M | Sell |
31,941
-4,589
| -13% | -$1.39M | 0.53% | 43 |
|
|
2019
Q3 | $10.6M | Buy |
36,530
+577
| +2% | +$165K | 0.51% | 44 |
|
|
2019
Q2 | $10.6M | Sell |
35,953
-3,941
| -10% | -$1.09M | 0.5% | 46 |
|
|
2019
Q1 | $10.9M | Buy |
39,894
+1,267
| +3% | +$315K | 0.57% | 40 |
|
|
2018
Q4 | $8.65M | Buy |
38,627
+8,523
| +28% | +$2M | 0.53% | 46 |
|
|
2018
Q3 | $7.35M | Sell |
30,104
-25,958
| -46% | -$5.97M | 0.35% | 65 |
|
|
2018
Q2 | $11.6M | Buy |
56,062
+12,023
| +27% | +$2.55M | 0.4% | 69 |
|
|
2018
Q1 | $9.1M | Buy |
44,039
+6,470
| +17% | +$1.36M | 0.32% | 76 |
|
|
2017
Q4 | $7.14M | Buy |
37,569
+4,631
| +14% | +$887K | 0.24% | 101 |
|
|
2017
Q3 | $6.24M | Sell |
32,938
-5,450
| -14% | -$987K | 0.22% | 112 |
|
|
2017
Q2 | $6.7M | Sell |
38,388
-5,385
| -12% | -$905K | 0.25% | 106 |
|
|
2017
Q1 | $6.73M | Buy |
43,773
+4,406
| +11% | +$673K | 0.27% | 93 |
|
|
2016
Q4 | $5.56M | Buy |
39,367
+1,834
| +5% | +$270K | 0.24% | 109 |
|
|
2016
Q3 | $5.97M | Sell |
37,533
-960
| -2% | -$148K | 0.27% | 93 |
|
|
2016
Q2 | $5.69M | Sell |
38,493
-4,285
| -10% | -$632K | 0.25% | 92 |
|
|
2016
Q1 | $6.33M | Buy |
42,778
+17,344
| +68% | +$2.32M | 0.29% | 78 |
|
|
2015
Q4 | $3.61M | Buy |
25,434
+416
| +2% | +$55.5K | 0.23% | 91 |
|
|
2015
Q3 | $3.06M | Sell |
25,018
-2,695
| -10% | -$351K | 0.3% | 85 |
|
|
2015
Q2 | $3.6M | Buy |
+27,713
| New | +$3.61M | 0.29% | 83 |
|
Other funds holding TMO
Tredje AP-fonden's TMO Position: Q2 2026 in Review
Tredje AP-fonden reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $7.87M and leaving 115,995 shares worth $58.2M. The position accounts for 0.26% of the portfolio, ranked #70.
Tredje AP-fonden first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $89.6M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Tredje AP-fonden held 115,995 shares of Thermo Fisher Scientific worth $58.2M as of Q2 2026.
- Tredje AP-fonden sold 16,389 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.87M.
- Thermo Fisher Scientific made up 0.26% of Tredje AP-fonden's portfolio in Q2 2026, its #70 holding.
- Tredje AP-fonden first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
- Tredje AP-fonden's Thermo Fisher Scientific position peaked at $89.6M in Q4 2025.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.